ESOP27 Oct 2026, 01:57 pm
Cipla Ltd Grants ESOS & ESAR Options
AI Summary
Cipla Ltd has announced grants under its Employee Stock Option Scheme 2013-A (ESOS 2013-A) and Employee Stock Appreciation Rights Scheme 2021 (ESAR 2021). The company granted 8,679 stock options under ESOS 2013-A with a 2-year vesting period and a 5-year exercise period post-vesting. Additionally, 27,140 Employee Stock Appreciation Rights (ESARs) were granted under ESAR 2021, featuring a 3-year graded vesting period and a 5-year exercise period post-vesting. The exercise price for stock options is ₹2 per option, and for ESARs, it is ₹2 per equity share. The Board meeting where these grants were approved concluded today.
Key Highlights
- Cipla Ltd granted 8,679 stock options under ESOS 2013-A.
- 27,140 ESARs were granted under the ESAR 2021 scheme.
- Vesting periods range from 2 to 3 years.
- Exercise periods are 5 years post-vesting for both schemes.
Price Impact
More from CIPLA